241 related articles for article (PubMed ID: 26711503)
21. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.
Latouche A; Allignol A; Beyersmann J; Labopin M; Fine JP
J Clin Epidemiol; 2013 Jun; 66(6):648-53. PubMed ID: 23415868
[TBL] [Abstract][Full Text] [Related]
22. Semiparametric regression on cumulative incidence function with interval-censored competing risks data.
Bakoyannis G; Yu M; Yiannoutsos CT
Stat Med; 2017 Oct; 36(23):3683-3707. PubMed ID: 28608412
[TBL] [Abstract][Full Text] [Related]
23. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
Austin PC; Allignol A; Fine JP
J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
[TBL] [Abstract][Full Text] [Related]
24. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry.
Lau B; Cole SR; Gange SJ
Stat Med; 2011 Mar; 30(6):654-65. PubMed ID: 21337360
[TBL] [Abstract][Full Text] [Related]
25. A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
Cantagallo E; De Backer M; Kicinski M; Ozenne B; Collette L; Legrand C; Buyse M; Péron J
Biom J; 2021 Feb; 63(2):272-288. PubMed ID: 32939818
[TBL] [Abstract][Full Text] [Related]
26. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
27. Tree-based models for survival data with competing risks.
Kretowska M
Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
[TBL] [Abstract][Full Text] [Related]
28. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
[TBL] [Abstract][Full Text] [Related]
29. Communicating and understanding statistical measures when quantifying the between-group difference in competing risks.
Wu H; Zhang C; Hou Y; Chen Z
Int J Epidemiol; 2023 Dec; 52(6):1975-1983. PubMed ID: 37738672
[TBL] [Abstract][Full Text] [Related]
30. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
Austin PC; Steyerberg EW; Putter H
Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
[TBL] [Abstract][Full Text] [Related]
31. Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice.
Jachno K; Heritier S; Wolfe R
BMC Med Res Methodol; 2019 May; 19(1):103. PubMed ID: 31096924
[TBL] [Abstract][Full Text] [Related]
32. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
Tai BC; Machin D; White I; Gebski V;
Stat Med; 2001 Mar; 20(5):661-84. PubMed ID: 11241570
[TBL] [Abstract][Full Text] [Related]
33. Simulating competing risks data in survival analysis.
Beyersmann J; Latouche A; Buchholz A; Schumacher M
Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
[TBL] [Abstract][Full Text] [Related]
34. Quantifying time-varying cause-specific hazard and subdistribution hazard ratios with competing risks data.
Diao G; Ibrahim JG
Clin Trials; 2019 Aug; 16(4):363-374. PubMed ID: 31165631
[TBL] [Abstract][Full Text] [Related]
35. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.
Beyersmann J; Dettenkofer M; Bertz H; Schumacher M
Stat Med; 2007 Dec; 26(30):5360-9. PubMed ID: 17634974
[TBL] [Abstract][Full Text] [Related]
36. Simulating recurrent event data with hazard functions defined on a total time scale.
Jahn-Eimermacher A; Ingel K; Ozga AK; Preussler S; Binder H
BMC Med Res Methodol; 2015 Mar; 15():16. PubMed ID: 25886022
[TBL] [Abstract][Full Text] [Related]
37. The proportional odds cumulative incidence model for competing risks.
Eriksson F; Li J; Scheike T; Zhang MJ
Biometrics; 2015 Sep; 71(3):687-95. PubMed ID: 26013050
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
[TBL] [Abstract][Full Text] [Related]
39. Flexible parametric modelling of the cause-specific cumulative incidence function.
Lambert PC; Wilkes SR; Crowther MJ
Stat Med; 2017 Apr; 36(9):1429-1446. PubMed ID: 28008649
[TBL] [Abstract][Full Text] [Related]
40. Instrumental variable with competing risk model.
Zheng C; Dai R; Hari PN; Zhang MJ
Stat Med; 2017 Apr; 36(8):1240-1255. PubMed ID: 28064466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
